Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 06

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 respiratory diagnosis host health asthma children SARS transplant cough hepatitis CAP bacterial gastroenteritis COVID-19 HIV
2 viruses clinical response approaches exacerbations infants influenza recipients upper viral infections canine % diarrhea myocarditis RVP
3 tract management immune care COPD bronchiolitis syndrome transplantation otitis viral KD infections MS cardiac plasma
4 respiratory viruses pediatric infection healthcare wheezing age severe organ media feline pneumoniae viral rotavirus athletes antibody
5 virus infectious cells nosocomial exacerbation pregnancy ARDS stem rhinitis virus CIRD bacterial infections enteric sudden hiv-infected
6 infections patient pathogenesis control airway countries coronavirus solid URI immunodeficiency agent articles calves sars-cov-2 immunodeficiencies
7 viral diagnostic responses burden obstructive RSV pandemic hematopoietic sinusitis viral diseases horses viral infections ADEM medications hiv infection
8 influenza based immune response economic HRV states mers-cov risk otitis media liver dogs microbiota bovine heart pidds
9 human sepsis innate impact chronic obstructive pulmonary disease united acute respiratory syndrome infections AOM cats CIRDC bacterial infection viral gastroenteritis vasculitides A.
10 syncytial therapy viral continue chronic young east cell acute herpes europe results cattle URS perioperative
11 lower treatment disease global development 5 H1N1 patients pharyngitis felv ecov colonization astroviruses CV DLB
12 pathogens presentation animal prevention CF pneumonia MERS SOT cold AIDS microscopy antibiotics dehydration systemic PID
13 respiratory syncytial virus infectious diseases system remain rhinovirus united states H5N1 mortality airway CMV atypical microbial diarrhoea cardiomyopathy replacement
14 common discussed models interventions acute exacerbations death coronaviruses HSCT acute otitis media simplex electron PRRSV rehydration dissemination immunoglobulin replacement therapy
15 parainfluenza imaging damage current inflammation deaths middle solid organ transplant rhinosinusitis latent chlamydia eos vomiting involvement antiretroviral
16 respiratory tract infections pneumonia model rtis risk % distress opportunistic CRS reactivation lesions compared acute gastroenteritis heart failure pids
17 antiviral differential mechanisms measures lung women hcov-nl63 fungal throat examples mycoplasma objective calf keratoconjunctivitis res
18 metapneumovirus approach role drugs early life hospitalization avian rejection upper respiratory tract infections infections rats urinary water 2019 titre
19 agents complications virus significant mechanisms years humans population nose epstein-barr pathogens PCT sclerosis hadv proteome-patterns
20 associated with resistance viral infection transmission life developing coagulation invasive ear epstein-barr virus zooepidemicus MEDLINE multiple sclerosis obesity hayden
21 detection pulmonary infections interactions prevent recurrent vitamin acute respiratory distress syndrome early influenzae EBV electron microscopy secondary rotaviruses comorbidities antivir
22 clinical emergency understood public airways elderly © cancer common immune suppression amplification study parvum therapy molecules
23 respiratory infections specific virus infection strategies inception stillbirths hcov morbidity bronchitis viruses multiplex positive rotavirus infection injury homes
24 hmpv evaluation immunity therapies asthma exacerbations infant seasonal fungal infections OM cytomegalovirus epidemiological controls caliciviruses exercise F.G.
25 influenza virus article lung source wheeze million strains carvs upper airway hemorrhagic equine 1918 BHV1 disease humoral
26 upper etiologies immune system therapeutic early mortality strain graft acute cough herpes simplex virus S. driven food pre-existing deficiency
27 techniques severity animal models morbidity RV developing countries sars-cov immunosuppressive obstruction ZIKV sequencing distinguish result hypertension adolescents
28 molecular suspected immune responses therapeutic approaches allergic estimated copyright opportunistic infections sinus virus infections mycoplasma pneumoniae published enteritis thymus humoral immunity
29 causative laboratory development review pulmonary aged 2009 prophylaxis chronic cough ocular samples studies encephalitis adenoviral J.
30 respiratory viral infections chapter respiratory tract treatment childhood vitamin d wiley early diagnosis haemophilus intensity CHV mixed C. ventricular residents
31 influenza viruses community-acquired pneumonia CNS discuss illnesses maternal 2012 immunocompromised epiglottitis DHF/DSS chlamydia pneumoniae streptococcal noroviruses dilated SMA
32 pneumonia commonly pigs management virus-induced pregnant spread risk factors trachea glomerular ecov infection concomitant intestine HAPE 1664–1672
33 HMPV diseases factors treat lung function cause of john neutropenia laryngitis ADE - end dairy IDC microbiol
34 human metapneumovirus differential diagnosis susceptibility neonates evidence year sons allograft etiology acquired immunodeficiency syndrome infectious agents tract encephalomyelitis arrhythmias pitkaranta
35 acute pulmonary expression potential disease admission IAV transplants OME diseases legionella applications loss altitude niederman
36 adults care adaptive due infancy accounts human coronaviruses prevention rhinorrhea viral infection epidemiological data calprotectin young sarcoidosis arruda
37 illness important cytokines active microbiome organization hcovs therapy uris persistent molecular epidemiology analyzed species cardiomyocytes anzueto
38 respiratory tract infection syndrome virome terms factors worldwide respiratory recipient haemophilus influenzae HSV M. carried demyelinating failure R.B.
39 polymerase common mice infections infections BRSV transmission treatment sore throat herpes viruses bronchoalveolar lavage statistically significant addressed vasculitis M.S.
40 bocavirus clinicians production search childhood asthma world health organization mers-cov infection infection middle ear enhancement arteritis mycobacterial norovirus patients 8
41 infection cases receptors paediatric hrvs risk hcov-229e strategies viral upper respiratory tract infection IFN-I panel antibiotic norwalk treatment sickle
42 article travelers mucosal SUMMARY bronchial severe mode of lung transplantation sneezing FIV clinical signs nasal young animals topical primary immunodeficiencies
43 rvis presenting invasion preventing role number nile posttransplant nasopharynx caused version lanyards foodborne acute cardiac injury 123
44 symptoms nature respiratory REVIEW children prematurity human allo-hsct urtis infection anorexia idea relapsing aerosol +
45 reaction aid understanding public health cystic decreases caused allogeneic ARS glomerulonephritis kennelled disease development carbohydrate coronavirus disease 2019 CM
46 persons physicians fully FINDINGS cystic fibrosis DV mortality rate factors sinuses feline immunodeficiency virus FMDV healthy controls diarrheal ang-(1 encounters
47 disease microbiological innate immune response workers wheezing illnesses adults virulent CARV symptoms marmosets crcov nasal microbiota abdominal pneumoconioses half-life
48 chain empiric multifactorial quality of life associated with pregnant women poultry post-transplant bacterial latency authorized nasal swabs gastrointestinal left nursing homes
49 acute respiratory tract infections disease studies PURPOSE atopy difficulty respiratory distress syndrome gram-negative tract VHF users HBP humans survey viral antigens
50 neuraminidase infections porcine travellers atopic hypertonic arabia CRV congestion relating pneumovirus signatures chapter beryllium sickle cell disease